Sight Sciences, Inc. (SGHT)
8.43
+0.01
(+0.12%)
USD |
NASDAQ |
Sep 03, 13:24
Sight Sciences Total Liabilities (Quarterly) : 51.98M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.98M |
| March 31, 2026 | 55.80M |
| December 31, 2025 | 51.36M |
| September 30, 2025 | 51.97M |
| June 30, 2025 | 51.96M |
| March 31, 2025 | 52.05M |
| December 31, 2024 | 55.32M |
| September 30, 2024 | 48.64M |
| June 30, 2024 | 48.08M |
| March 31, 2024 | 46.35M |
| December 31, 2023 | 46.44M |
| September 30, 2023 | 49.57M |
| Date | Value |
|---|---|
| June 30, 2023 | 49.16M |
| March 31, 2023 | 50.26M |
| December 31, 2022 | 53.00M |
| September 30, 2022 | 52.30M |
| June 30, 2022 | 48.99M |
| March 31, 2022 | 46.68M |
| December 31, 2021 | 48.08M |
| September 30, 2021 | 45.07M |
| June 30, 2021 | 169.80M |
| March 31, 2021 | 161.33M |
| December 31, 2020 | 161.66M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 2.520B |
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 104.87M |
| Shareholders Equity (Quarterly) | 52.89M |
| Debt to Equity Ratio | 0.7935 |
| Current Ratio | 4.948 |
| Net Debt Paydown Yield | -0.10% |